Usefulness of a novel classification based on perioperative changes of membranous urethral length using hierarchical cluster analysis of urinary incontinence and overactive bladder symptoms after robot-assisted radical prostatectomy: A prospective observational study.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
11 2019
Historique:
received: 15 05 2019
accepted: 02 07 2019
pubmed: 25 7 2019
medline: 21 5 2020
entrez: 25 7 2019
Statut: ppublish

Résumé

The aim of the present study was to construct a novel classification based on perioperative changes of membranous urethral length (MUL) using hierarchical cluster analysis to predict urinary incontinence (UI) and overactive bladder (OAB) symptoms after robot-assisted radical prostatectomy (RARP). A total of 299 patients who underwent RARP with complete pre and postoperative MUL data were included in the present study. Hierarchical cluster analysis was performed to identify the groups with similar perioperative MUL and prostate size. UI and OAB symptoms after RARP were evaluated in each cluster for 12 months after RARP. Four groups were identified by the cluster analysis of these factors: preservation of MUL type (cluster 1, n = 92); standard type (cluster 2, n = 137); large prostate type (cluster 3, n = 23); and loss of MUL type (cluster 4, n = 47). Although there was significantly more UI in clusters 3 and 4 than in clusters 1 and 2 up to 3 months after RARP, UI improvement was the most delayed in cluster 3. Improvement of OAB symptoms was also most delayed in cluster 3. Urinary quality of life (QOL) was significantly worse in cluster 4 than in clusters 1 and 2. Cluster analysis successfully classified patients after RARP into four characteristic groups based on perioperative MUL. Recovery from UI and OAB symptoms and urinary QOL after RARP were significantly different among these groups. This classification based on cluster analysis might be useful to predict recovery from UI and OAB symptoms when following QOL after RARP.

Identifiants

pubmed: 31338904
doi: 10.1002/nau.24117
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2200-2208

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Mitsutaka Onoda (M)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Department of Urology, Iwate Medical University School of Medicine, Morioka, Japan.

Nobuhiro Haga (N)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Yoshimasa Kurimura (Y)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Ryo Tanji (R)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Akifumi Onagi (A)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Ruriko Honda (R)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Kanako Matsuoka (K)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Seiji Hoshi (S)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Tomoyuki Koguchi (T)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Junya Hata (J)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Yuichi Sato (Y)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Hidenori Akaihata (H)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Masao Kataoka (M)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Soichiro Ogawa (S)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Wataru Obara (W)

Department of Urology, Iwate Medical University School of Medicine, Morioka, Japan.

Yoshiyuki Kojima (Y)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH